Divi's Laboratories announced a robust financial performance for the March quarter of FY25, with a 25.6% YoY surge in standalone net profit, reaching Rs 667 crore. Revenue from operations also climbed by 12.26% to Rs 2,536 crore. The company's board declared a dividend of Rs 30 per share and (...)
Site référencé: The Economic Times
The Economic Times
IndusInd Bank to declare Q4, FY25 results on May 21
17/05/2025
Moody's strips U.S. government of top credit rating, citing Washington's failure to rein in debt
17/05/2025
RBI FY25 payout to govt may jump 50 per cent
16/05/2025
Obesity drug maker Novo Nordisk ousts CEO as competition weighs
16/05/2025
Citi to cut up to 200 tech contractor roles in China, sources say
16/05/2025
Trump says many in Gaza are 'starving'
16/05/2025
